Amerise Biosciences Ltd
Amerise Biosciences Ltd (AMERISE): company summary
The company's business has not generated any revenue or profit in the latest fiscal year or quarter, despite a reported 36.8% annual revenue growth and a 100.0% annual net profit increase.
Amerise Biosciences Ltd (AMERISE) is a micro-cap Industrial Products company valued at ₹5 crore operating in Plastic Products - Industrial on the NSE and BSE.
- Recent price move
- Amerise Biosciences Ltd last traded at ₹0.81, down 3.57% on the day.
- Financial performance
- The company's business has not generated any revenue or profit in the latest fiscal year or quarter, despite a reported 36.8% annual revenue growth and a 100.0% annual net profit increase. The latest quarter shows a widening loss compared to the same quarter a year earlier, with both revenue and net profit remaining at zero.
- Valuation multiples
- A price-to-earnings ratio is not meaningful here; the stock trades at 1.00 times book value.
- Things to watch
- The company has not reported any revenue or profit in the latest quarter or fiscal year, and its net profit margin, while up, is based on zero figures. The stock is 18.4% below its 52-week high, and the company has no promoter holding, which may indicate a lack of strategic direction or control.
- Where it stands
- Amerise Biosciences Ltd has not generated any revenue or profit in the latest quarter or fiscal year, with both figures remaining at zero. The stock is 18.4% below its 52-week high, and the company has no promoter holding, which may indicate a lack of strategic direction or control.
Summarised by DocStoX's model on 2026-10-18 from company filings, exchange data and news. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.
Price performance
Supported by growth (7.5) and momentum (6.2), but held back by quality (2.6). Growth looks strong at 7.5, but that is offset by quality at 2.6. We are calling it Mixed rather than resolving the conflict for you.
DocStoX score
Low confidenceAt a glance
Key highlights
- Revenue compounding 196% a year
- Low leverage — D/E 0.00
- Loss-making — no meaningful P/E
- Loss-making in some of the last 5 years
Growth
Financials
Technicals
Peers
News
Forecasts
About the company
More data
Filings, corporate actions and ownership detail — opened on demand.
More Industrial Products stocks · Plastic Products - Industrial
Explore Amerise Biosciences Ltd’s valuation
Free deep-dive tools · no sign-up
Amerise Biosciences Ltd peers in Industrial Products
Other Industrial Products stocks on the NSE & BSE. See the full Industrial Products sector list.
Related tools & concepts
Value Amerise Biosciences Ltd with the ratios and calculators DocStoX uses in its analysis.

